Brief: Tenaya Therapeutics Inc - On Mar 27, Co Approves Restructuring Plan - SEC Filing
28/03/2025 20:13
March 28 (Reuters) - Tenaya Therapeutics Inc TNYA.O: TENAYA THERAPEUTICS INC - ON MAR 27, CO APPROVES RESTRUCTURING PLAN - SEC FILING TENAYA THERAPEUTICS INC - RESTRUCTURING PLAN TO REDUCE CASH EXPENSES - SEC FILING TENAYA THERAPEUTICS INC - RESTRUCTURING PLAN TO EXTEND CASH RUNWAY INTO H2 2026 - SEC FILING TENAYA THERAPEUTICS INC - TO REDUCE WORKFORCE UNDER RESTRUCTURING PLAN - SEC FILING TENAYA THERAPEUTICS INC - TO INCUR $1.6 MILLION-$2.7 MILLION IN RESTRUCTURING CHARGES - SEC FILING TENAYA THERAPEUTICS INC - EXPECTS TO RECOGNIZE CHARGES BY Q3 2025 - SEC FILING Source text: [ID:n0001193125-25-067071] Further company coverage: TNYA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tenaya Therapeutics
See all newsBrief: Tenaya Therapeutics Announces Interim Data From Mypeak™-1 Showing Treatment Of Mybpc3-Associated Hcm With TN-201 Gene Therapy Resulted In Consistent Signs Of Cardiac Remodeling And Reductions In Symptoms
Brief: Positive Interim Data From Cohorts 1 And 2 Of Tenaya's Ridge-1 Phase 1B/2 Clinical Trial Of TN-401
Tenaya Therapeutics Q1 net loss widens, misses analyst expectations
Brief: Tenaya Therapeutics Q1 Net Income USD -19.272 Million
Tenaya Therapeutics' Q4 net loss narrows, extends cash runway into H2 2027